The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Utilization of metastatic hormone sensitive prostate cancer (mHSPC) treatment in a community oncology practice setting.
 
Terri Conner
Employment - Vidence
Research Funding - Abbvie (Inst); Aileron Therapeutics (Inst); AstraZeneca (Inst); Bayer (Inst); Taiho Pharmaceutical (Inst)
 
Sreevalsa Appukkuttan
Employment - Bayer
Stock and Other Ownership Interests - Bayer
 
Sheldon Kong
Employment - Bayer
Stock and Other Ownership Interests - Bayer
Travel, Accommodations, Expenses - Bayer
 
Jay Jhaveri
Employment - Bayer; Eisai
Stock and Other Ownership Interests - GlaxoSmithKline
 
Gilbert Ko
Employment - Bayer
Stock and Other Ownership Interests - Bayer
Research Funding - Bayer
Travel, Accommodations, Expenses - Bayer
 
Bashir Kalayeh
Employment - Bayer
Stock and Other Ownership Interests - Bayer
Research Funding - Bayer
Expert Testimony - Bayer
 
LiHong He
Employment - Vidence
Research Funding - Abbvie (Inst); Aileron Therapeutics (Inst); AstraZeneca (Inst); Bayer (Inst); Taiho Pharmaceutical (Inst)
 
Robert Sean Hauser
Employment - Vidence
Leadership - Vidence
Stock and Other Ownership Interests - Amgen; Novartis; Vertex
Research Funding - Abbvie (Inst); Aileron Therapeutics (Inst); AstraZeneca (Inst); Bayer (Inst); Taiho Pharmaceutical (Inst)
 
Arturo Loaiza-Bonilla
Stock and Other Ownership Interests - Massive Bio
Consulting or Advisory Role - Bayer; BrightInsight; Cardinal Health; Eisai; Massive Bio; Pfizer; PSI
Speakers' Bureau - Amgen; AstraZeneca/Daiichi Sankyo; Bayer; Guardant Health; Ipsen